Literature DB >> 8784268

Strain-related differences in the ability of T lymphocytes to recognize proteins encoded by the golli-myelin basic protein gene.

H Pitchekian-Halabi1, C W Campagnoni, E Skinner, K Kampf, A T Campagnoni, R R Voskuhl.   

Abstract

Protein products of the golli-MBP gene complex, expressed in the nervous and lymphoid systems, contain sequences in common with sequences in 'classic' MBP, expressed exclusively in the nervous system. In this report, it was determined whether T cell lines (TCLs) specific for encephalitogenic epitopes of 'classic' MBP were able to recognize sequences within golli-MBP. TCLs derived from SJL mice specific for the immunodominant 83-102 sequence and the subdominant 19-27 sequence of 'classic' MBP recognized golli-MBP J37 and BG21, respectively. In contrast, TCLs derived from PL and B10.PL mice specific for the immunodominant 1-9 sequence of 'classic' MBP did not recognize this sequence within either J37 or BG21. These strain-related differences in the ability of golli-MBP proteins to stimulate 'classic' MBP-specific TCLs are discussed with respect to a possible influence on whether the course of EAE is relapsing (SJL) or monophasic (PL and B10.PL).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784268     DOI: 10.1016/0165-5728(96)00084-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Minireview: expression and function of golli protein in immune system.

Authors:  Ji-Ming Feng
Journal:  Neurochem Res       Date:  2006-10-06       Impact factor: 3.996

Review 2.  Immune tolerance in multiple sclerosis.

Authors:  Joan M Goverman
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 3.  Immune tolerance to myelin proteins.

Authors:  Audrey Seamons; Antoine Perchellet; Joan Goverman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis.

Authors:  Sergey A Shiryaev; Alexei Y Savinov; Piotr Cieplak; Boris I Ratnikov; Khatereh Motamedchaboki; Jeffrey W Smith; Alex Y Strongin
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.